Results 361 to 370 of about 425,993 (391)
Some of the next articles are maybe not open access.
Seminars in Immunopathology, 2012
Chronic hepatitis C virus (HCV) infection is associated with an increase in hepatic steatosis and a decrease in serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL) and apolipoprotein B (apoB), the main protein constituent of LDL and very low-density lipoprotein (VLDL).
Margaret Bassendine +4 more
openaire +3 more sources
Chronic hepatitis C virus (HCV) infection is associated with an increase in hepatic steatosis and a decrease in serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL) and apolipoprotein B (apoB), the main protein constituent of LDL and very low-density lipoprotein (VLDL).
Margaret Bassendine +4 more
openaire +3 more sources
Inhibition of HCV Replication in HCV Replicon by shRNAs
Nucleosides, Nucleotides and Nucleic Acids, 2006We show that the vector-derived long dsRNA specifically inhibits the replication of HCV RNA in HCV replicon. We designed a long dsRNA targeted to the full-length HCV IRES/core elements (1-to 377-nt). Our results revealed that the replication of HCV RNA was reduced to near background levels in a sequence-specific manner by the long dsRNAs in the HCV ...
Hiroshi Takaku +4 more
openaire +3 more sources
HCV seroreactivity and detection of HCV RNA in cirrhotics
Diagnostic Microbiology and Infectious Disease, 1999This study was carried out to determine the presence of HCV infection in cirrhotic patients and to compare their serologic profiles with detection of HCV RNA by RT-PCR. Liver function profiles were assessed and correlated with infection. Coinfection of HCV with HBV was studied in the Indian context Sera from 62 patients of biopsy confirmed cirrhosis ...
Premashis Kar +5 more
openaire +2 more sources
Lymphocyte Subsets in Hemodialyzed HCV+ and HCV– Patients
Nephron, 1998The aim of our study was to get information on the immune status of patients who undergo haemodialysis in the presence of an HCV infection. This virus infects not only hepatocytes, but also blood mononuclear cells, in particular B cells [1], but we do not know the role of this lymphocyte involvement in the maintenance and progression of hepatitis.
F Bruschi +6 more
openaire +3 more sources
Acta Obstetricia et Gynecologica Scandinavica, 1998
Knowledge about vertical transmission of HCV is still limited. In this study we followed up the virological status of a series of offspring born to anti-HCV positive, anti-HIV negative mothers.Between January 1993 and January 1995, 5000 consecutive, anti-HIV negative pregnant women were screened for anti-HCV (ELISA III) and all positive samples were ...
A. La Torre +8 more
openaire +5 more sources
Knowledge about vertical transmission of HCV is still limited. In this study we followed up the virological status of a series of offspring born to anti-HCV positive, anti-HIV negative mothers.Between January 1993 and January 1995, 5000 consecutive, anti-HIV negative pregnant women were screened for anti-HCV (ELISA III) and all positive samples were ...
A. La Torre +8 more
openaire +5 more sources
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
Atherosclerosis, 2012HCV and NAFLD are associated with atherosclerosis in general population. The prevalence of atherosclerosis in chronic hepatitis C (CHC) patients is unknown. We hypothesized that HCV per se and HCV-related steatosis could favour atherosclerosis. Thus, in CHC patients we assessed: (a) the prevalence of atherosclerosis; (b) the role of HCV, cardio ...
ADINOLFI, Luigi Elio +8 more
openaire +4 more sources
2004
Discussion of the etiologic role of HCV in mixed ...
FERRI, Clodoveo, Bombardieri S.
openaire +2 more sources
Discussion of the etiologic role of HCV in mixed ...
FERRI, Clodoveo, Bombardieri S.
openaire +2 more sources
Clinics and Research in Hepatology and Gastroenterology, 2021
Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is estimated at about 71 million people worldwide by World Health Organization (WHO) with at least 400,000 people that died every year from HCV disease [1].
Alexandra Ducancelle +4 more
openaire +3 more sources
Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is estimated at about 71 million people worldwide by World Health Organization (WHO) with at least 400,000 people that died every year from HCV disease [1].
Alexandra Ducancelle +4 more
openaire +3 more sources
Hepatology, 2019
Direct‐acting antiviral (DAA) therapy has altered the frequency and outcome of liver transplantation (LT) for hepatitis C virus (HCV). The high efficacy and tolerability of DAA therapy has also created a rationale for utilizing HCV‐viremic (HCV‐RNA ...
T. Cotter +7 more
semanticscholar +1 more source
Direct‐acting antiviral (DAA) therapy has altered the frequency and outcome of liver transplantation (LT) for hepatitis C virus (HCV). The high efficacy and tolerability of DAA therapy has also created a rationale for utilizing HCV‐viremic (HCV‐RNA ...
T. Cotter +7 more
semanticscholar +1 more source
HBV/HCV Coinfection in the Era of HCV-DAAs
Clinics in Liver Disease, 2019Epidemiologic studies suggest that 10% to 15% of patients infected with hepatitis C virus (HCV) are coinfected with hepatitis B virus (HBV) in the United States as a result of the shared modality of transmission, but the true prevalence is not known.
Mohamed El Kabany +2 more
openaire +3 more sources